{"id":306,"date":"2021-10-14T13:05:18","date_gmt":"2021-10-14T11:05:18","guid":{"rendered":"https:\/\/miopia.pl\/conference-2026\/strona-glowna\/"},"modified":"2026-06-03T14:12:37","modified_gmt":"2026-06-03T12:12:37","slug":"strona-glowna","status":"publish","type":"page","link":"https:\/\/miopia.pl\/conference-2026\/","title":{"rendered":"Homepage"},"content":{"rendered":"<section class=\"l-section wpb_row height_auto width_full\"><div class=\"l-section-h i-cf\"><div class=\"g-cols vc_row via_flex valign_top type_default stacking_default\"><div class=\"vc_col-sm-12 wpb_column vc_column_container\"><div class=\"vc_column-inner\"><div class=\"wpb_wrapper\"><div class=\"w-image align_center\"><div class=\"w-image-h\"><img loading=\"lazy\" decoding=\"async\" width=\"1920\" height=\"1080\" src=\"https:\/\/miopia.pl\/conference-2026\/wp-content\/uploads\/2026\/02\/Conference-Miopia-2026.jpg\" class=\"attachment-full size-full\" alt=\"\" srcset=\"https:\/\/miopia.pl\/conference-2026\/wp-content\/uploads\/2026\/02\/Conference-Miopia-2026.jpg 1920w, https:\/\/miopia.pl\/conference-2026\/wp-content\/uploads\/2026\/02\/Conference-Miopia-2026-300x169.jpg 300w, https:\/\/miopia.pl\/conference-2026\/wp-content\/uploads\/2026\/02\/Conference-Miopia-2026-150x84.jpg 150w\" sizes=\"(max-width: 1920px) 100vw, 1920px\" \/><\/div><\/div><div class=\"w-separator size_medium\"><\/div><\/div><\/div><\/div><\/div><\/div><\/section><section class=\"l-section wpb_row us_custom_242268fa height_medium\" id=\"program\"><div class=\"l-section-overlay\" style=\"background:#f0f0f6\"><\/div><div class=\"l-section-h i-cf\"><div class=\"g-cols vc_row via_flex valign_top type_default stacking_default\"><div class=\"vc_col-sm-12 wpb_column vc_column_container\"><div class=\"vc_column-inner\"><div class=\"wpb_wrapper\"><div class=\"w-separator us_custom_dd184a0a size_custom with_line width_default thick_5 style_solid color_secondary align_center\" style=\"height:5px\"><div class=\"w-separator-h\"><\/div><\/div><div class=\"w-separator size_medium\" id=\"sd87\"><style>@media(max-width:1024px){ #sd87{height:5rem!important}}@media(max-width:600px){ #sd87{height:4rem!important}}<\/style><\/div><h2 class=\"w-text us_custom_03b3ee3e\"><span class=\"w-text-h\"><span class=\"w-text-value\">Online Conference Agenda \u2013 Myopia 2026<\/span><\/span><\/h2><h3 class=\"w-text us_custom_aa271a07\"><span class=\"w-text-h\"><span class=\"w-text-value\">June 5, 2026 | Central European Summer Time (CEST)<\/span><\/span><\/h3><div class=\"w-separator size_medium\" id=\"f0e2\"><style>@media(max-width:1024px){ #f0e2{height:5rem!important}}@media(max-width:600px){ #f0e2{height:4rem!important}}<\/style><\/div><div class=\"w-hwrapper align_none valign_top\" style=\"--hwrapper-gap:0\"><div class=\"w-vwrapper align_none valign_top\"><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><p>3:00\u00a0 &#8211;\u00a0 3.05 PM<\/p>\n<\/div><\/div><\/div><div class=\"w-vwrapper align_none valign_top\"><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><p><strong>Opening of the conference<\/strong> \u2013 Prof. Andrzej Grzybowski, MD, PhD, Foundation for Supporting the Development of Ophthalmology \u201cOphthalmology 21\u201d, University of Warmia and Mazury, Olsztyn, Poland<\/p>\n<\/div><\/div><\/div><\/div><div class=\"w-hwrapper align_none valign_top\" style=\"--hwrapper-gap:0\"><div class=\"w-vwrapper align_none valign_top\"><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><p>3.05 &#8211; 3.21 PM<\/p>\n<\/div><\/div><\/div><div class=\"w-vwrapper align_none valign_top\"><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><p><strong>Introductory lecture \u2013 Myopia prevention and control: it is time to measure what we do<\/strong>, Prof. Serge Resnikoff, MD, PhD, The Chair of the International Myopia Institute<\/p>\n<\/div><\/div><\/div><\/div><div class=\"w-separator us_custom_dd184a0a size_custom with_line width_default thick_5 style_solid color_secondary align_center\" style=\"height:5px\"><div class=\"w-separator-h\"><\/div><\/div><div class=\"w-separator size_medium\" id=\"gc79\"><style>@media(max-width:1024px){ #gc79{height:5rem!important}}@media(max-width:600px){ #gc79{height:4rem!important}}<\/style><\/div><div class=\"w-hwrapper align_none valign_top\" style=\"--hwrapper-gap:0\"><div class=\"w-vwrapper align_center valign_top\"><div class=\"w-separator size_small\"><\/div><\/div><div class=\"w-vwrapper align_none valign_top\"><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><p><strong>Session I<\/strong><\/p>\n<\/div><\/div><\/div><\/div><div class=\"w-separator us_custom_dd184a0a size_custom with_line width_default thick_5 style_solid color_secondary align_center\" style=\"height:5px\"><div class=\"w-separator-h\"><\/div><\/div><div class=\"w-separator size_medium\" id=\"d0a8\"><style>@media(max-width:1024px){ #d0a8{height:5rem!important}}@media(max-width:600px){ #d0a8{height:4rem!important}}<\/style><\/div><div class=\"w-hwrapper align_none valign_top\" style=\"--hwrapper-gap:0\"><div class=\"w-vwrapper align_none valign_top\"><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><p>3.21 &#8211; 3.32 PM<\/p>\n<\/div><\/div><\/div><div class=\"w-vwrapper align_none valign_top\"><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><p><strong>Possible effect of Induced Spherical Aberrations (Z04) on Myopia Control by OrthoKeratology.<\/strong> Dr. Andriy Kovalov, MD, PhD. Ophthalmologist Consultant of AILAS Medical Center (Kyiv, Ukraine)<\/p>\n<\/div><\/div><\/div><\/div><div class=\"w-hwrapper align_none valign_top\" style=\"--hwrapper-gap:0\"><div class=\"w-vwrapper align_none valign_top\"><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><p>3.32 &#8211; 3.41 PM<\/p>\n<\/div><\/div><\/div><div class=\"w-vwrapper align_none valign_top\"><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><p><strong>Indications of favorable structural changes during ortho-k treatment.<\/strong> Dr. Trine M\u00f8ldrup Jakobsen, MD, PhD, Department of Ophthalmology, University Hospital of Southern Denmark; Institution of Regional Research, University of Southern Denmark, S\u00f8nderborg, Denmark<\/p>\n<\/div><\/div><\/div><\/div><div class=\"w-hwrapper align_none valign_top\" style=\"--hwrapper-gap:0\"><div class=\"w-vwrapper align_none valign_top\"><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><p>3.41 &#8211; 3.50 PM<\/p>\n<\/div><\/div><\/div><div class=\"w-vwrapper align_none valign_top\"><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><p><strong>Twenty Years of Orthokeratology in Real Life: Efficacy, Safety and Predictors of Myopia Progression.<\/strong> Dr. Beata Tapaszt\u00f3, MD, PhD, Semmelweis University, Department of Ophthalmology, Budapest, Hungary; Semmelweis University, Faculty of Health Sciences, Budapest, Hungary<\/p>\n<\/div><\/div><\/div><\/div><div class=\"w-hwrapper align_none valign_top\" style=\"--hwrapper-gap:0\"><div class=\"w-vwrapper align_none valign_top\"><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><p>3.50 \u2013 4.00 PM<\/p>\n<\/div><\/div><\/div><div class=\"w-vwrapper align_none valign_top\"><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><p><strong>The evaluation of methods and the success of optical interventions in a real-world population.<\/strong> Dr. Mhairi Day PhD, the Department of Vision Sciences at Glasgow Caledonian University, Scotland, UK<\/p>\n<\/div><\/div><\/div><\/div><div class=\"w-hwrapper align_none valign_top\" style=\"--hwrapper-gap:0\"><div class=\"w-vwrapper align_none valign_top\"><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><p>4.00 &#8211; 4.10 PM<\/p>\n<\/div><\/div><\/div><div class=\"w-vwrapper align_none valign_top\"><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><p><strong>Myopia and strabismus<\/strong>. Prof. Pilar Merino Sanz, MD, PhD, Department of Ophthalmology, Hospital Universitario Gregorio Mara\u00f1\u00f3n, Madrid, Spain; President of the Spanish Society of Strabismus and Pediatric Ophthalmology (SEEOP)<\/p>\n<\/div><\/div><\/div><\/div><div class=\"w-hwrapper align_none valign_top\" style=\"--hwrapper-gap:0\"><div class=\"w-vwrapper align_none valign_top\"><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><p>4.10 &#8211; 4.20 PM<\/p>\n<\/div><\/div><\/div><div class=\"w-vwrapper align_none valign_top\"><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><p><strong>Raising the Bar in Myopia Control with MiYOSMART iQ: 12-month randomized controlled clinical trial results.<\/strong> Sylwia Kijewska, Hoya Lens Poland (sponsored lecture)<\/p>\n<\/div><\/div><\/div><\/div><div class=\"w-hwrapper align_none valign_top\" style=\"--hwrapper-gap:0\"><div class=\"w-vwrapper align_none valign_top\"><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><p>4.20 &#8211; 4.27 PM<\/p>\n<\/div><\/div><\/div><div class=\"w-vwrapper align_none valign_top\"><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><p><strong>Implementing Interdisciplinary Clinical Workflows in Modern Myopia Managemen<\/strong>t, Max Aricochi, M.Sc., Eye Centre Kettenbr\u00fccke, Austria, the European Academy of Optometry and Optics.<\/p>\n<\/div><\/div><\/div><\/div><div class=\"w-hwrapper align_none valign_top\" style=\"--hwrapper-gap:0\"><div class=\"w-vwrapper align_none valign_top\"><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><p>4.27 &#8211; 4.39 PM<\/p>\n<\/div><\/div><\/div><div class=\"w-vwrapper align_none valign_top\"><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><p><strong>Early-life emmetropisation is independent of subsequent refractive error development.<\/strong>\u00a0Dr. Sotiris Plainis, MSc, PhD, Laboratory of Optics and Vision, School of Medicine, University of Crete, Heraklion, Greece; Honorary Research Fellow at the University of Manchester, UK<\/p>\n<\/div><\/div><\/div><\/div><div class=\"w-hwrapper align_none valign_top\" style=\"--hwrapper-gap:0\"><div class=\"w-vwrapper align_none valign_top\"><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><p>4.39 &#8211; 4.49 PM<\/p>\n<\/div><\/div><\/div><div class=\"w-vwrapper align_none valign_top\"><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><p><strong>Choroidal thickness and myopia.<\/strong> Dr. Matteo Baldi MD, PhD Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, and Maternal and Child Health, University of Genoa, Italy.<\/p>\n<\/div><\/div><\/div><\/div><div class=\"w-hwrapper align_none valign_top\" style=\"--hwrapper-gap:0\"><div class=\"w-vwrapper align_none valign_top\"><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><p>4.49 &#8211; 5.00 PM<\/p>\n<\/div><\/div><\/div><div class=\"w-vwrapper align_none valign_top\"><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><p><strong>Empowering Clinical Excellence with Robust Evidence: Seven Key Facts of Essilor\u00ae Stellest\u00ae Lenses<\/strong>, Gabi Steenbekkers BOptom. FBCLA, Global Medical Advisor \u2013 Myopia, EssilorLuxottica (sponsored lecture)<\/p>\n<\/div><\/div><\/div><\/div><div class=\"w-hwrapper align_none valign_top\" style=\"--hwrapper-gap:0\"><div class=\"w-vwrapper align_none valign_top\"><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><p>5.00 &#8211; 5.15 PM<\/p>\n<\/div><\/div><\/div><div class=\"w-vwrapper align_none valign_top\"><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><p><strong>Discussion<\/strong> \u2013 Speakers and conference participants, moderated by Prof. Pilar Merino Sanz, MD, PhD, Department of Ophthalmology, Hospital Universitario Gregorio Mara\u00f1\u00f3n, Madrid, Spain; President of the Spanish Society of Strabismus and Pediatric Ophthalmology (SEEOP)<\/p>\n<\/div><\/div><\/div><\/div><div class=\"w-separator us_custom_dd184a0a size_custom with_line width_default thick_5 style_solid color_secondary align_center\" style=\"height:5px\"><div class=\"w-separator-h\"><\/div><\/div><div class=\"w-separator size_medium\" id=\"b14f\"><style>@media(max-width:1024px){ #b14f{height:5rem!important}}@media(max-width:600px){ #b14f{height:4rem!important}}<\/style><\/div><div class=\"w-hwrapper align_none valign_top\" style=\"--hwrapper-gap:0\"><div class=\"w-vwrapper align_center valign_top\"><div class=\"w-separator size_small\"><\/div><\/div><div class=\"w-vwrapper align_none valign_top\"><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><p><strong>Session II (5:15 \u2013 7:10 PM)<\/strong><\/p>\n<\/div><\/div><\/div><\/div><div class=\"w-separator us_custom_dd184a0a size_custom with_line width_default thick_5 style_solid color_secondary align_center\" style=\"height:5px\"><div class=\"w-separator-h\"><\/div><\/div><div class=\"w-separator size_medium\" id=\"p51b\"><style>@media(max-width:1024px){ #p51b{height:5rem!important}}@media(max-width:600px){ #p51b{height:4rem!important}}<\/style><\/div><div class=\"w-hwrapper align_none valign_top\" style=\"--hwrapper-gap:0\"><div class=\"w-vwrapper align_none valign_middle\"><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><p>5.15 &#8211; 5.25 PM<\/p>\n<\/div><\/div><\/div><div class=\"w-vwrapper align_none valign_top\"><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><p><strong>Reporting myopia-control efficacy as physiological axial growth and NNT (number needed to treat).<\/strong> Prof. Hakan Kaymak, MD, PhD, I.I.O. GbR, D\u00fcsseldorf, Germany; Gottfried O.H. Naumann Institute for Epidemiology and Prevention of Myopia, Saarland University, Homburg, Germany<\/p>\n<\/div><\/div><\/div><\/div><div class=\"w-hwrapper align_none valign_top\" style=\"--hwrapper-gap:0\"><div class=\"w-vwrapper align_none valign_middle\"><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><p>5.25 &#8211; 5.36 PM<\/p>\n<\/div><\/div><\/div><div class=\"w-vwrapper align_none valign_top\"><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><p><strong>Light-Based Interventions to Slow Myopia Progression: Current Evidence.<\/strong> Prof. Carla Lanca, PhD, New York University Abu Dhabi, UAE<\/p>\n<\/div><\/div><\/div><\/div><div class=\"w-hwrapper align_none valign_top\" style=\"--hwrapper-gap:0\"><div class=\"w-vwrapper align_none valign_middle\"><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><p>5.36 &#8211; 5.47 PM<\/p>\n<\/div><\/div><\/div><div class=\"w-vwrapper align_none valign_top\"><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><p><strong>Update on the Prevalence of Myopia in Europe.<\/strong> Prof. Miguel \u00c1. S\u00e1nchez-Tena, PhD (Department of Optometry and Vision, Complutense University of Madrid, Spain) and Prof. Cristina Alvarez-Peregrina PhD (Complutense University of Madrid, Spain)<\/p>\n<\/div><\/div><\/div><\/div><div class=\"w-hwrapper align_none valign_top\" style=\"--hwrapper-gap:0\"><div class=\"w-vwrapper align_none valign_middle\"><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><p>5.47 &#8211; 5.57 PM<\/p>\n<\/div><\/div><\/div><div class=\"w-vwrapper align_none valign_top\"><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><p><strong>Association of time spent on near work and outdoors with the prevalence and progression of myopia.<\/strong> Prof. Olavi P\u00e4rssinen MD, PhD, CREAM Consortium, MRC Consortium, Finland<\/p>\n<\/div><\/div><\/div><\/div><div class=\"w-hwrapper align_none valign_top\" style=\"--hwrapper-gap:0\"><div class=\"w-vwrapper align_none valign_middle\"><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><p>5.57 &#8211; 6.07 PM<\/p>\n<\/div><\/div><\/div><div class=\"w-vwrapper align_none valign_top\"><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><p><strong>Who Should Be Treated for Myopia?<\/strong> Dr. Jelena \u0160kunca Herman, MD, PhD, Department of Pediatric Ophthalmology and Strabismus, Sestre milosrdnice University Hospital Center, Zagreb, Croatia<\/p>\n<\/div><\/div><\/div><\/div><div class=\"w-hwrapper align_none valign_top\" style=\"--hwrapper-gap:0\"><div class=\"w-vwrapper align_none valign_middle\"><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><p>6.07 &#8211; 6.15 PM<\/p>\n<\/div><\/div><\/div><div class=\"w-vwrapper align_none valign_top\"><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><p><strong>Population study \u2013 Myopia screening among first-grade students in Troms\u00f8, Norway.<\/strong> Dr. Aleksandar Stojanovic, MD, PhD, FWCRS, University Hospital of North Norway, Troms\u00f8, Norway; SynsLaser Surgery Clinics, Troms\u00f8 and Oslo, Norway<\/p>\n<\/div><\/div><\/div><\/div><div class=\"w-hwrapper align_none valign_top\" style=\"--hwrapper-gap:0\"><div class=\"w-vwrapper align_none valign_middle\"><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><p>6.15 &#8211; 6.25 PM<\/p>\n<\/div><\/div><\/div><div class=\"w-vwrapper align_none valign_top\"><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><p><strong>One-year efficacy and tolerability of 0.05% atropine for myopia control in Estonia<\/strong>, Teele Palumaa, MD, DPhil, Department of Ophthalmology, Emory University, USA, Institute of Genomics, University of Tartu, Estonia<\/p>\n<\/div><\/div><\/div><\/div><div class=\"w-hwrapper align_none valign_top\" style=\"--hwrapper-gap:0\"><div class=\"w-vwrapper align_none valign_middle\"><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><p>6.25 &#8211; 6.35 PM<\/p>\n<\/div><\/div><\/div><div class=\"w-vwrapper align_none valign_top\"><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><p><strong>Do children use myopia lenses as expected,<\/strong> Dr Pablo Concepci\u00f3n-Grande PhD, IOT Lenses and Szajna Soczewki Okularowe (sponsored lecture)<\/p>\n<\/div><\/div><\/div><\/div><div class=\"w-hwrapper align_none valign_top\" style=\"--hwrapper-gap:0\"><div class=\"w-vwrapper align_none valign_middle\"><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><p>6.35 &#8211; 6.45 PM<\/p>\n<\/div><\/div><\/div><div class=\"w-vwrapper align_none valign_top\"><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><p><strong>\u201cUnderstanding Parental Perceptions and Barriers to Myopia Control Uptake\u201d<\/strong> Dr S\u00edofra Harrington, PhD, FAOI, FEAOO, Technological University Dublin, the Centre for Eye Research Ireland (CERI), Ireland<\/p>\n<\/div><\/div><\/div><\/div><div class=\"w-hwrapper align_none valign_top\" style=\"--hwrapper-gap:0\"><div class=\"w-vwrapper align_none valign_middle\"><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><p>6.45 &#8211; 6.55 PM<\/p>\n<\/div><\/div><\/div><div class=\"w-vwrapper align_none valign_top\"><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><p><strong>&#8220;The use of 0.01% atropine in myopia control.&#8221;\u00a0<\/strong> Prof. Andrzej Grzybowski, MD, PhD, Foundation for Supporting the Development of Ophthalmology \u201cOphthalmology 21\u201d, University of Warmia and Mazury, Olsztyn, Poland (sponsored lecture)<\/p>\n<\/div><\/div><\/div><\/div><div class=\"w-hwrapper align_none valign_top\" style=\"--hwrapper-gap:0\"><div class=\"w-vwrapper align_none valign_middle\"><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><p>6.55 &#8211; 7.10 PM<\/p>\n<\/div><\/div><\/div><div class=\"w-vwrapper align_none valign_top\"><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><p><strong>Discussion<\/strong> \u2013 Speakers and conference participants, moderated by Prof. Andrzej Grzybowski, MD, PhD, Foundation for Supporting the Development of Ophthalmology \u201cOphthalmology 21\u201d, University of Warmia and Mazury, Olsztyn, Poland<\/p>\n<\/div><\/div><\/div><\/div><div class=\"w-separator us_custom_dd184a0a size_custom with_line width_default thick_5 style_solid color_secondary align_center\" style=\"height:5px\"><div class=\"w-separator-h\"><\/div><\/div><div class=\"w-separator size_medium\" id=\"x547\"><style>@media(max-width:1024px){ #x547{height:5rem!important}}@media(max-width:600px){ #x547{height:4rem!important}}<\/style><\/div><div class=\"w-hwrapper align_none valign_top\" style=\"--hwrapper-gap:0\"><div class=\"w-vwrapper align_none valign_middle\"><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><p>7.10 &#8211; 7.15 PM<\/p>\n<\/div><\/div><\/div><div class=\"w-vwrapper align_none valign_top\"><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><p><strong>Closing of the conference<\/strong> \u2013 Prof. Andrzej Grzybowski, MD, PhD, Foundation for Supporting the Development of Ophthalmology \u201cOphthalmology 21\u201d, University of Warmia and Mazury, Olsztyn, Poland<\/p>\n<\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/section>\n","protected":false},"excerpt":{"rendered":"Online Conference Agenda \u2013 Myopia 2026June 5, 2026 | Central European Summer Time (CEST)3:00\u00a0 &#8211;\u00a0 3.05 PM Opening of the conference \u2013 Prof. Andrzej Grzybowski, MD, PhD, Foundation for Supporting the Development of Ophthalmology \u201cOphthalmology 21\u201d, University of Warmia and Mazury, Olsztyn, Poland 3.05 &#8211; 3.21 PM Introductory lecture \u2013 Myopia prevention and control: it...","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":3,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"acf":[],"_links":{"self":[{"href":"https:\/\/miopia.pl\/conference-2026\/wp-json\/wp\/v2\/pages\/306"}],"collection":[{"href":"https:\/\/miopia.pl\/conference-2026\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/miopia.pl\/conference-2026\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/miopia.pl\/conference-2026\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/miopia.pl\/conference-2026\/wp-json\/wp\/v2\/comments?post=306"}],"version-history":[{"count":100,"href":"https:\/\/miopia.pl\/conference-2026\/wp-json\/wp\/v2\/pages\/306\/revisions"}],"predecessor-version":[{"id":1506,"href":"https:\/\/miopia.pl\/conference-2026\/wp-json\/wp\/v2\/pages\/306\/revisions\/1506"}],"wp:attachment":[{"href":"https:\/\/miopia.pl\/conference-2026\/wp-json\/wp\/v2\/media?parent=306"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}